Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice
Psychomotor effects elicited by systemic administration of the noncompetitive NMDA ( N-methyl- d-aspartate) receptor antagonist MK-801 (dizocilpine maleate) represent perturbation of glutamatergic pathways, providing an animal model for psychotic symptoms of schizophrenia. Hyperlocomotion and stereo...
Saved in:
Published in | European journal of pharmacology Vol. 580; no. 1; pp. 161 - 168 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
02.02.2008
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Psychomotor effects elicited by systemic administration of the noncompetitive NMDA (
N-methyl-
d-aspartate) receptor antagonist MK-801 (dizocilpine maleate) represent perturbation of glutamatergic pathways, providing an animal model for psychotic symptoms of schizophrenia. Hyperlocomotion and stereotypy are the two main psychomotor behaviors induced by MK-801. This study compared MK-801-induced hyperlocomotion and stereotypy in young (1-month old) and aged mice (12-month old), in order to determine how the aging process may influence these behaviors. The tested MK-801 doses ranged from 0.015 to 1 mg/kg. The data indicated that MK-801 impacted the aged mice more pronouncedly than the young mice, as both hyperlocomotion and stereotypy were increased significantly more in the aged mice relative to the young mice. These results suggest an age-related increase in MK-801 sensitivity in mice. |
---|---|
AbstractList | Psychomotor effects elicited by systemic administration of the noncompetitive NMDA (N-methyl-D-aspartate) receptor antagonist MK-801 (dizocilpine maleate) represent perturbation of glutamatergic pathways, providing an animal model for psychotic symptoms of schizophrenia. Hyperlocomotion and stereotypy are the two main psychomotor behaviors induced by MK-801. This study compared MK-801-induced hyperlocomotion and stereotypy in young (1-month old) and aged mice (12-month old), in order to determine how the aging process may influence these behaviors. The tested MK-801 doses ranged from 0.015 to 1 mg/kg. The data indicated that MK-801 impacted the aged mice more pronouncedly than the young mice, as both hyperlocomotion and stereotypy were increased significantly more in the aged mice relative to the young mice. These results suggest an age-related increase in MK-801 sensitivity in mice. Psychomotor effects elicited by systemic administration of the noncompetitive NMDA ( N-methyl- d-aspartate) receptor antagonist MK-801 (dizocilpine maleate) represent perturbation of glutamatergic pathways, providing an animal model for psychotic symptoms of schizophrenia. Hyperlocomotion and stereotypy are the two main psychomotor behaviors induced by MK-801. This study compared MK-801-induced hyperlocomotion and stereotypy in young (1-month old) and aged mice (12-month old), in order to determine how the aging process may influence these behaviors. The tested MK-801 doses ranged from 0.015 to 1 mg/kg. The data indicated that MK-801 impacted the aged mice more pronouncedly than the young mice, as both hyperlocomotion and stereotypy were increased significantly more in the aged mice relative to the young mice. These results suggest an age-related increase in MK-801 sensitivity in mice. |
Author | Zou, Hong Jin, Meilei Qi, Chunting Zhang, Ruizhong Zhao, Guoping Yu, Lei |
AuthorAffiliation | b Department of Genetics and Center of Alcohol Studies, Rutgers University, 607 Allison Road, Piscataway, New Jersey 08854, USA a Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Cao Bao Road, Shanghai 200233, China |
AuthorAffiliation_xml | – name: a Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Cao Bao Road, Shanghai 200233, China – name: b Department of Genetics and Center of Alcohol Studies, Rutgers University, 607 Allison Road, Piscataway, New Jersey 08854, USA |
Author_xml | – sequence: 1 givenname: Chunting surname: Qi fullname: Qi, Chunting organization: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Cao Bao Road, Shanghai 200233, China – sequence: 2 givenname: Hong surname: Zou fullname: Zou, Hong organization: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Cao Bao Road, Shanghai 200233, China – sequence: 3 givenname: Ruizhong surname: Zhang fullname: Zhang, Ruizhong organization: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Cao Bao Road, Shanghai 200233, China – sequence: 4 givenname: Guoping surname: Zhao fullname: Zhao, Guoping organization: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Cao Bao Road, Shanghai 200233, China – sequence: 5 givenname: Meilei surname: Jin fullname: Jin, Meilei email: mljin@sibs.ac.cn organization: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 500 Cao Bao Road, Shanghai 200233, China – sequence: 6 givenname: Lei surname: Yu fullname: Yu, Lei email: yu@biology.rutgers.edu organization: Department of Genetics and Center of Alcohol Studies, Rutgers University, 607 Allison Road, Piscataway, New Jersey 08854, USA |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20040578$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18053981$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEtPGzEUhS1EBYHyD1DlDcsJfsyMx5tKEPWBmqobWLuOfQ2OJnZkm0j59zgkArqpdCVb8jnH93xn6DjEAAhdUjKlhPbXyyks1086TRkhYvo69AhN6CBkU6_sGE0IoW3DpJSn6CznJSGkk6w7Qad0IB2XA52gvzeP0CQYdQGLrXcOEoTi9YgzhOyL3_iyxSXi37-agdDGB_tsqnSMJq5i8TFgHSzOpfpi2a632Ac868Tt_LrHK2_gM_rk9Jjh4nCeo4fv3-5nP5v5nx93s5t5Y1pJS0M57xzXdb2Bdky6gfCFdo7pRc8ltbJlTlvXO-4WAtpeCNmz1pCWdIPgrbX8HH3d566fFyuwprZIelTr5Fc6bVXUXv37EvyTeowbxUSl0tMa0O4DTIo5J3BvXkrUjrhaqj1xtSOuXmdn-_Lx33fTAXEVXB0EOhs9uqSD8flNV7NqCTG8F4BKaeMhqWw8hArbJzBF2ej_v8kL696jJg |
CODEN | EJPHAZ |
CitedBy_id | crossref_primary_10_1002_glia_22469 crossref_primary_10_1016_j_bbr_2012_10_013 crossref_primary_10_1016_j_neuropharm_2010_07_004 crossref_primary_10_1016_j_neuropharm_2020_108103 crossref_primary_10_1016_j_ejphar_2009_11_012 crossref_primary_10_1371_journal_pone_0022716 crossref_primary_10_1016_j_jveb_2017_02_006 crossref_primary_10_1016_j_jpsychires_2012_09_005 crossref_primary_10_1016_j_neulet_2014_12_019 crossref_primary_10_1038_mp_2017_237 crossref_primary_10_1111_j_1742_7843_2010_00552_x crossref_primary_10_1016_j_bbr_2024_115049 crossref_primary_10_2217_fnl_12_54 crossref_primary_10_3389_fncel_2022_1070015 crossref_primary_10_1016_j_neuropharm_2011_06_027 crossref_primary_10_1016_j_jneumeth_2024_110072 crossref_primary_10_1016_j_ejphar_2009_10_068 crossref_primary_10_1186_1744_9081_6_7 |
Cites_doi | 10.1016/S0006-3223(99)00117-1 10.1016/0047-6374(95)01658-9 10.1016/j.biopsych.2005.08.029 10.1097/00002826-199710000-00001 10.1007/s002210050544 10.1016/j.neulet.2004.02.064 10.1016/S0014-2999(99)00070-9 10.1016/S0197-4580(98)00058-X 10.1016/0014-2999(89)90754-1 10.1016/0014-2999(75)90072-2 10.1016/S0169-328X(01)00344-8 10.1016/S0006-3223(01)01346-4 10.1002/j.1875-9114.1996.tb02920.x 10.1016/0014-2999(92)90029-4 10.1016/S0896-6273(03)00757-8 10.1007/s002130051055 10.1016/S0006-8993(02)04088-X 10.1007/BF01258633 10.1016/j.pnpbp.2005.03.004 10.1016/0006-8993(75)90233-4 10.1016/0304-3940(80)90178-0 10.1016/S0197-4580(02)00232-4 10.1006/exnr.2001.7737 10.1007/BF01245040 10.1016/0166-2236(90)90108-M 10.1016/0014-2999(75)90326-X 10.1016/0014-2999(76)90096-0 10.1016/S0006-8993(01)02601-4 10.1002/ddr.430020204 10.1007/s00213-004-1944-1 |
ContentType | Journal Article |
Copyright | 2007 Elsevier B.V. 2008 INIST-CNRS |
Copyright_xml | – notice: 2007 Elsevier B.V. – notice: 2008 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1016/j.ejphar.2007.07.071 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1879-0712 |
EndPage | 168 |
ExternalDocumentID | 10_1016_j_ejphar_2007_07_071 18053981 20040578 S0014299907012381 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: R21 DA020555-02 – fundername: NIDA NIH HHS grantid: R01 DA013471-06 – fundername: NIDA NIH HHS grantid: DA020555 – fundername: NIDA NIH HHS grantid: DA013471 – fundername: NIDA NIH HHS grantid: R21 DA020555 – fundername: NIDA NIH HHS grantid: R01 DA013471 |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29G 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXLA AAXUO ABCQJ ABFNM ABFRF ABJNI ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMQ HMT HVGLF HZ~ IHE J1W K-O KOM L7B M2V M34 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SES SEW SNS SPCBC SPT SSN SSP SSZ T5K TEORI WUQ X7M ZGI ~G- 08R AAPBV AAUGY ABPIF ABPTK IQODW AAXKI AKRWK CGR CUY CVF ECM EIF NPM AAYXX AFJKZ CITATION 5PM |
ID | FETCH-LOGICAL-c491t-1335f3a92581529f803baff2ab6391d942fadf6f3fb7e46779624c04058734dd3 |
IEDL.DBID | AIKHN |
ISSN | 0014-2999 |
IngestDate | Tue Sep 17 21:10:53 EDT 2024 Thu Sep 26 18:59:37 EDT 2024 Sat Sep 28 07:55:21 EDT 2024 Sun Oct 22 16:08:25 EDT 2023 Fri Feb 23 02:16:15 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Differential drug sensitivity Aging Locomotion Noncompetitive NMDA receptor antagonist Dizocilpine maleate Stereotypy Drug Senescence Dizocilpine Rodentia Neuroprotective agent Glutamate receptor Vertebrata Sensitivity Mammalia Mouse Animal Antagonist NMDA receptor Age |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c491t-1335f3a92581529f803baff2ab6391d942fadf6f3fb7e46779624c04058734dd3 |
Notes | Send proofs to: Lei Yu, Department of Genetics & Center of Alcohol Studies, Rutgers University, 607 Allison Road, Piscataway, New Jersey 08854-8001, USA; Tel.: +1-732-445-0794, fax: +1-732-445-3500, E-mail: yu@biology.rutgers.edu |
OpenAccessLink | https://europepmc.org/articles/pmc2705961?pdf=render |
PMID | 18053981 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2705961 crossref_primary_10_1016_j_ejphar_2007_07_071 pubmed_primary_18053981 pascalfrancis_primary_20040578 elsevier_sciencedirect_doi_10_1016_j_ejphar_2007_07_071 |
PublicationCentury | 2000 |
PublicationDate | 2008-02-02 |
PublicationDateYYYYMMDD | 2008-02-02 |
PublicationDate_xml | – month: 02 year: 2008 text: 2008-02-02 day: 02 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | European journal of pharmacology |
PublicationTitleAlternate | Eur J Pharmacol |
PublicationYear | 2008 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Carlsson, Carlsson (bib2) 1989; 75 Carlsson, Carlsson (bib3) 1990; 13 Segal, Kuczenski (bib28) 1987; 242 Schiffelholz, Hinze-Selch, Aldenhoff (bib27) 2004; 360 Magnusson (bib18) 1995; 84 Kelly, Seviour, Iversen (bib14) 1975; 94 Kim, Kornhuber, Schmid-Burgk, Holzmuller (bib15) 1980; 20 Moghaddam (bib21) 2003; 40 Loscher, Honack (bib17) 1992; 215 Rung, Carlsson, Ryden, Carlsson (bib26) 2005; 29 Carlsson, Waters, Carlsson (bib4) 1999; 46 Tricklebank, Singh, Oles, Preston, Iversen (bib32) 1989; 167 Tiedtke, Bischoff, Schmidt (bib31) 1990; 81 Magnusson, Nelson, Young (bib19) 2002; 99 Adriani, Felici, Sargolini, Roullet, Usiello, Oliverio, Mele (bib1) 1998; 123 Clineschmidt, Martin, Bunting, Papp (bib5) 1982; 2 Thornberg, Saklad (bib30) 1996; 16 Deutsch, Rosse, Mastropaolo (bib9) 1997; 20 Ossowska, Wolfarth, Schulze, Wardas, Pietraszek, Lorenc-Koci, Smialowska, Coper (bib24) 2001; 907 Suzuki, Takagi, Nakamura, Hashimoto, Umemura (bib29) 2003; 964 Costall, Naylor (bib6) 1975; 32 Costall, Naylor, Neumeyer (bib8) 1975; 31 Frantz, Van Hartesveldt (bib10) 1999; 369 Mitchell, Anderson (bib20) 1998; 19 O'Neill, Shaw (bib23) 1999; 145 Rujescu, Bender, Keck, Hartmann, Ohl, Raeder, Giegling, Genius, McCarley, Moller, Grunze (bib25) 2006; 59 Haggerty, Brown (bib11) 1996; 17 Nishith, Griffin, Poth (bib22) 2002; 51 Institute of Laboratory Animal Resources (bib12) 1996 Vasilev, Veskov, Janac, Rakic, Stojiljkovic (bib33) 2003; 24 Wu, Zou, Strong, Yu, Zhou, Xie, Zhao, Jin, Yu (bib35) 2005; 177 Javitt (bib13) 1987; 9 Villares, Stavale (bib34) 2001; 171 Costall, Naylor (bib7) 1976; 36 Kuczenski, Segal (bib16) 1999; 288 2550253 - Eur J Pharmacol. 1989 Aug 11;167(1):127-35 15916843 - Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):827-32 10494572 - Psychopharmacology (Berl). 1999 Aug;145(3):237-50 15290006 - Psychopharmacology (Berl). 2005 Jan;177(3):256-63 9331513 - Clin Neuropharmacol. 1997 Oct;20(5):375-84 9835392 - Exp Brain Res. 1998 Nov;123(1-2):52-9 11430887 - Brain Res. 2001 Jul 13;907(1-2):71-83 2820854 - Hillside J Clin Psychiatry. 1987;9(1):12-35 1171714 - Brain Res. 1975 Sep 5;94(3):507-22 945168 - Eur J Pharmacol. 1976 Apr;36(2):423-9 9662001 - Neurobiol Aging. 1998 May-Jun;19(3):259-65 8788777 - Mech Ageing Dev. 1995 Oct 27;84(3):227-43 10578453 - Biol Psychiatry. 1999 Nov 15;46(10):1388-95 11573991 - Exp Neurol. 2001 Oct;171(2):391-404 2538557 - J Neural Transm. 1989;75(3):221-6 16427029 - Biol Psychiatry. 2006 Apr 15;59(8):721-9 14659087 - Neuron. 2003 Dec 4;40(5):881-4 10206172 - Eur J Pharmacol. 1999 Mar 19;369(2):145-57 3656119 - J Pharmacol Exp Ther. 1987 Sep;242(3):917-26 8700797 - Pharmacotherapy. 1996 Jan-Feb;16(1):82-93 1168579 - Eur J Pharmacol. 1975 Mar;31(1):1-16 12022959 - Biol Psychiatry. 2002 Jun 1;51(11):867-74 1171020 - Eur J Pharmacol. 1975 May;32(1):87-92 1975747 - J Neural Transm Gen Sect. 1990;81(3):173-82 12885579 - Neurobiol Aging. 2003 Sep;24(5):715-23 15082157 - Neurosci Lett. 2004 Apr 29;360(3):157-60 1695402 - Trends Neurosci. 1990 Jul;13(7):272-6 6108541 - Neurosci Lett. 1980 Dec;20(3):379-82 11869807 - Brain Res Mol Brain Res. 2002 Feb 28;99(1):40-5 9086514 - Neurotoxicology. 1996 Fall-Winter;17(3-4):913-21 9918578 - J Pharmacol Exp Ther. 1999 Feb;288(2):699-709 12573519 - Brain Res. 2003 Feb 21;964(1):116-20 1356790 - Eur J Pharmacol. 1992 May 14;215(2-3):199-208 Vasilev (10.1016/j.ejphar.2007.07.071_bib33) 2003; 24 Tiedtke (10.1016/j.ejphar.2007.07.071_bib31) 1990; 81 Moghaddam (10.1016/j.ejphar.2007.07.071_bib21) 2003; 40 Frantz (10.1016/j.ejphar.2007.07.071_bib10) 1999; 369 Javitt (10.1016/j.ejphar.2007.07.071_bib13) 1987; 9 Haggerty (10.1016/j.ejphar.2007.07.071_bib11) 1996; 17 Rujescu (10.1016/j.ejphar.2007.07.071_bib25) 2006; 59 Suzuki (10.1016/j.ejphar.2007.07.071_bib29) 2003; 964 Costall (10.1016/j.ejphar.2007.07.071_bib7) 1976; 36 Kelly (10.1016/j.ejphar.2007.07.071_bib14) 1975; 94 Kim (10.1016/j.ejphar.2007.07.071_bib15) 1980; 20 Nishith (10.1016/j.ejphar.2007.07.071_bib22) 2002; 51 Deutsch (10.1016/j.ejphar.2007.07.071_bib9) 1997; 20 Ossowska (10.1016/j.ejphar.2007.07.071_bib24) 2001; 907 Adriani (10.1016/j.ejphar.2007.07.071_bib1) 1998; 123 Rung (10.1016/j.ejphar.2007.07.071_bib26) 2005; 29 Clineschmidt (10.1016/j.ejphar.2007.07.071_bib5) 1982; 2 Schiffelholz (10.1016/j.ejphar.2007.07.071_bib27) 2004; 360 Magnusson (10.1016/j.ejphar.2007.07.071_bib18) 1995; 84 Carlsson (10.1016/j.ejphar.2007.07.071_bib2) 1989; 75 O'Neill (10.1016/j.ejphar.2007.07.071_bib23) 1999; 145 Wu (10.1016/j.ejphar.2007.07.071_bib35) 2005; 177 Segal (10.1016/j.ejphar.2007.07.071_bib28) 1987; 242 Institute of Laboratory Animal Resources (10.1016/j.ejphar.2007.07.071_bib12) 1996 Carlsson (10.1016/j.ejphar.2007.07.071_bib3) 1990; 13 Thornberg (10.1016/j.ejphar.2007.07.071_bib30) 1996; 16 Loscher (10.1016/j.ejphar.2007.07.071_bib17) 1992; 215 Costall (10.1016/j.ejphar.2007.07.071_bib6) 1975; 32 Villares (10.1016/j.ejphar.2007.07.071_bib34) 2001; 171 Kuczenski (10.1016/j.ejphar.2007.07.071_bib16) 1999; 288 Tricklebank (10.1016/j.ejphar.2007.07.071_bib32) 1989; 167 Carlsson (10.1016/j.ejphar.2007.07.071_bib4) 1999; 46 Magnusson (10.1016/j.ejphar.2007.07.071_bib19) 2002; 99 Costall (10.1016/j.ejphar.2007.07.071_bib8) 1975; 31 Mitchell (10.1016/j.ejphar.2007.07.071_bib20) 1998; 19 |
References_xml | – volume: 99 start-page: 40 year: 2002 end-page: 45 ident: bib19 article-title: Age-related changes in the protein expression of subunits of the NMDA receptor publication-title: Brain Res. Mol. Brain Res. contributor: fullname: Young – volume: 75 start-page: 221 year: 1989 end-page: 226 ident: bib2 article-title: The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice publication-title: J. Neural Transm. contributor: fullname: Carlsson – volume: 215 start-page: 199 year: 1992 end-page: 208 ident: bib17 article-title: The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems publication-title: Eur. J. Pharmacol. contributor: fullname: Honack – volume: 29 start-page: 827 year: 2005 end-page: 832 ident: bib26 article-title: (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry. contributor: fullname: Carlsson – volume: 31 start-page: 1 year: 1975 end-page: 16 ident: bib8 article-title: Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas publication-title: Eur. J. Pharmacol. contributor: fullname: Neumeyer – volume: 288 start-page: 699 year: 1999 end-page: 709 ident: bib16 article-title: Sensitization of amphetamine-induced stereotyped behaviors during the acute response publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Segal – volume: 59 start-page: 721 year: 2006 end-page: 729 ident: bib25 article-title: A pharmacological model for psychosis based on publication-title: Biol. Psychiatry contributor: fullname: Grunze – volume: 369 start-page: 145 year: 1999 end-page: 157 ident: bib10 article-title: Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects publication-title: Eur. J. Pharmacol. contributor: fullname: Van Hartesveldt – volume: 242 start-page: 917 year: 1987 end-page: 926 ident: bib28 article-title: Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Kuczenski – volume: 81 start-page: 173 year: 1990 end-page: 182 ident: bib31 article-title: MK-801-induced stereotypy and its antagonism by neuroleptic drugs publication-title: J. Neural Transm. Gen. Sect. contributor: fullname: Schmidt – volume: 167 start-page: 127 year: 1989 end-page: 135 ident: bib32 article-title: The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor publication-title: Eur. J. Pharmacol. contributor: fullname: Iversen – volume: 9 start-page: 12 year: 1987 end-page: 35 ident: bib13 article-title: Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia publication-title: Hillside J. Clin. Psychiatr. contributor: fullname: Javitt – volume: 123 start-page: 52 year: 1998 end-page: 59 ident: bib1 article-title: publication-title: Exp. Brain Res. contributor: fullname: Mele – volume: 964 start-page: 116 year: 2003 end-page: 120 ident: bib29 article-title: Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats publication-title: Brain Res. contributor: fullname: Umemura – volume: 32 start-page: 87 year: 1975 end-page: 92 ident: bib6 article-title: The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system publication-title: Eur. J. Pharmacol. contributor: fullname: Naylor – volume: 24 start-page: 715 year: 2003 end-page: 723 ident: bib33 article-title: Age-related differences in MK-801-and amphetamine-induced locomotor and stereotypic activities of rats publication-title: Neurobiol. Aging contributor: fullname: Stojiljkovic – volume: 19 start-page: 259 year: 1998 end-page: 265 ident: bib20 article-title: Age-related changes in [3H]MK-801 binding in the Fischer 344 rat brain publication-title: Neurobiol. Aging contributor: fullname: Anderson – volume: 46 start-page: 1388 year: 1999 end-page: 1395 ident: bib4 article-title: Neurotransmitter interactions in schizophrenia-therapeutic implications publication-title: Biol. Psychiatry contributor: fullname: Carlsson – volume: 360 start-page: 157 year: 2004 end-page: 160 ident: bib27 article-title: Perinatal MK-801 treatment affects age-related changes in locomotor activity from childhood to later adulthood in rats publication-title: Neurosci. Lett. contributor: fullname: Aldenhoff – volume: 145 start-page: 237 year: 1999 end-page: 250 ident: bib23 article-title: Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice publication-title: Psychopharmacol. contributor: fullname: Shaw – volume: 13 start-page: 272 year: 1990 end-page: 276 ident: bib3 article-title: Interactions between glutamatergic and monoaminergic systems within the basal ganglia—implications for schizophrenia and Parkinson's disease publication-title: Trends NeuroSci. contributor: fullname: Carlsson – volume: 36 start-page: 423 year: 1976 end-page: 429 ident: bib7 article-title: Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias publication-title: Eur. J. Pharmacol. contributor: fullname: Naylor – volume: 84 start-page: 227 year: 1995 end-page: 243 ident: bib18 article-title: Differential effects of aging on binding sites of the activated NMDA receptor complex in mice publication-title: Mech. Ageing Dev. contributor: fullname: Magnusson – volume: 20 start-page: 375 year: 1997 end-page: 384 ident: bib9 article-title: Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice publication-title: Clin. Neuropharmacol. contributor: fullname: Mastropaolo – volume: 17 start-page: 913 year: 1996 end-page: 921 ident: bib11 article-title: Neurobehavioral profile of subcutaneously administered MK-801 in the rat publication-title: Neurotoxicology contributor: fullname: Brown – volume: 94 start-page: 507 year: 1975 end-page: 522 ident: bib14 article-title: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum publication-title: Brain Res. contributor: fullname: Iversen – volume: 20 start-page: 379 year: 1980 end-page: 382 ident: bib15 article-title: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia publication-title: Neurosci. Lett. contributor: fullname: Holzmuller – volume: 16 start-page: 82 year: 1996 end-page: 93 ident: bib30 article-title: A review of NMDA receptors and the phencyclidine model of schizophrenia publication-title: Pharmacotherapy contributor: fullname: Saklad – volume: 177 start-page: 256 year: 2005 end-page: 263 ident: bib35 article-title: Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice publication-title: Psychopharmacol. contributor: fullname: Yu – year: 1996 ident: bib12 publication-title: Guide for the care and use of laboratory animals contributor: fullname: Institute of Laboratory Animal Resources – volume: 171 start-page: 391 year: 2001 end-page: 404 ident: bib34 article-title: Age-related changes in the publication-title: Exp. Neurol. contributor: fullname: Stavale – volume: 51 start-page: 867 year: 2002 end-page: 874 ident: bib22 article-title: Stress-induced analgesia: prediction of posttraumatic stress symptoms in battered versus nonbattered women publication-title: Biol. Psychiatry contributor: fullname: Poth – volume: 907 start-page: 71 year: 2001 end-page: 83 ident: bib24 article-title: Decline in motor functions in aging is related to the loss of NMDA receptors publication-title: Brain Res. contributor: fullname: Coper – volume: 40 start-page: 881 year: 2003 end-page: 884 ident: bib21 article-title: Bringing order to the glutamate chaos in schizophrenia publication-title: Neuron contributor: fullname: Moghaddam – volume: 2 start-page: 135 year: 1982 end-page: 145 ident: bib5 article-title: Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [D]cyclohepten-5, 10-immine(MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties publication-title: Drug Dev. Res. contributor: fullname: Papp – volume: 46 start-page: 1388 year: 1999 ident: 10.1016/j.ejphar.2007.07.071_bib4 article-title: Neurotransmitter interactions in schizophrenia-therapeutic implications publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(99)00117-1 contributor: fullname: Carlsson – volume: 84 start-page: 227 year: 1995 ident: 10.1016/j.ejphar.2007.07.071_bib18 article-title: Differential effects of aging on binding sites of the activated NMDA receptor complex in mice publication-title: Mech. Ageing Dev. doi: 10.1016/0047-6374(95)01658-9 contributor: fullname: Magnusson – volume: 59 start-page: 721 year: 2006 ident: 10.1016/j.ejphar.2007.07.071_bib25 article-title: A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2005.08.029 contributor: fullname: Rujescu – volume: 20 start-page: 375 year: 1997 ident: 10.1016/j.ejphar.2007.07.071_bib9 article-title: Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice publication-title: Clin. Neuropharmacol. doi: 10.1097/00002826-199710000-00001 contributor: fullname: Deutsch – volume: 123 start-page: 52 year: 1998 ident: 10.1016/j.ejphar.2007.07.071_bib1 article-title: N-methyl-d-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes publication-title: Exp. Brain Res. doi: 10.1007/s002210050544 contributor: fullname: Adriani – volume: 360 start-page: 157 year: 2004 ident: 10.1016/j.ejphar.2007.07.071_bib27 article-title: Perinatal MK-801 treatment affects age-related changes in locomotor activity from childhood to later adulthood in rats publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2004.02.064 contributor: fullname: Schiffelholz – volume: 369 start-page: 145 year: 1999 ident: 10.1016/j.ejphar.2007.07.071_bib10 article-title: Locomotion elicited by MK801 in developing and adult rats: temporal, environmental, and gender effects publication-title: Eur. J. Pharmacol. doi: 10.1016/S0014-2999(99)00070-9 contributor: fullname: Frantz – volume: 19 start-page: 259 year: 1998 ident: 10.1016/j.ejphar.2007.07.071_bib20 article-title: Age-related changes in [3H]MK-801 binding in the Fischer 344 rat brain publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(98)00058-X contributor: fullname: Mitchell – volume: 167 start-page: 127 year: 1989 ident: 10.1016/j.ejphar.2007.07.071_bib32 article-title: The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(89)90754-1 contributor: fullname: Tricklebank – volume: 31 start-page: 1 year: 1975 ident: 10.1016/j.ejphar.2007.07.071_bib8 article-title: Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(75)90072-2 contributor: fullname: Costall – year: 1996 ident: 10.1016/j.ejphar.2007.07.071_bib12 contributor: fullname: Institute of Laboratory Animal Resources – volume: 99 start-page: 40 year: 2002 ident: 10.1016/j.ejphar.2007.07.071_bib19 article-title: Age-related changes in the protein expression of subunits of the NMDA receptor publication-title: Brain Res. Mol. Brain Res. doi: 10.1016/S0169-328X(01)00344-8 contributor: fullname: Magnusson – volume: 51 start-page: 867 year: 2002 ident: 10.1016/j.ejphar.2007.07.071_bib22 article-title: Stress-induced analgesia: prediction of posttraumatic stress symptoms in battered versus nonbattered women publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(01)01346-4 contributor: fullname: Nishith – volume: 242 start-page: 917 year: 1987 ident: 10.1016/j.ejphar.2007.07.071_bib28 article-title: Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Segal – volume: 16 start-page: 82 year: 1996 ident: 10.1016/j.ejphar.2007.07.071_bib30 article-title: A review of NMDA receptors and the phencyclidine model of schizophrenia publication-title: Pharmacotherapy doi: 10.1002/j.1875-9114.1996.tb02920.x contributor: fullname: Thornberg – volume: 215 start-page: 199 year: 1992 ident: 10.1016/j.ejphar.2007.07.071_bib17 article-title: The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(92)90029-4 contributor: fullname: Loscher – volume: 40 start-page: 881 year: 2003 ident: 10.1016/j.ejphar.2007.07.071_bib21 article-title: Bringing order to the glutamate chaos in schizophrenia publication-title: Neuron doi: 10.1016/S0896-6273(03)00757-8 contributor: fullname: Moghaddam – volume: 145 start-page: 237 year: 1999 ident: 10.1016/j.ejphar.2007.07.071_bib23 article-title: Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice publication-title: Psychopharmacol. doi: 10.1007/s002130051055 contributor: fullname: O'Neill – volume: 964 start-page: 116 year: 2003 ident: 10.1016/j.ejphar.2007.07.071_bib29 article-title: Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats publication-title: Brain Res. doi: 10.1016/S0006-8993(02)04088-X contributor: fullname: Suzuki – volume: 75 start-page: 221 year: 1989 ident: 10.1016/j.ejphar.2007.07.071_bib2 article-title: The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice publication-title: J. Neural Transm. doi: 10.1007/BF01258633 contributor: fullname: Carlsson – volume: 29 start-page: 827 year: 2005 ident: 10.1016/j.ejphar.2007.07.071_bib26 article-title: (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia publication-title: Prog. Neuropsychopharmacol. Biol. Psychiatry. doi: 10.1016/j.pnpbp.2005.03.004 contributor: fullname: Rung – volume: 94 start-page: 507 year: 1975 ident: 10.1016/j.ejphar.2007.07.071_bib14 article-title: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum publication-title: Brain Res. doi: 10.1016/0006-8993(75)90233-4 contributor: fullname: Kelly – volume: 20 start-page: 379 year: 1980 ident: 10.1016/j.ejphar.2007.07.071_bib15 article-title: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(80)90178-0 contributor: fullname: Kim – volume: 24 start-page: 715 year: 2003 ident: 10.1016/j.ejphar.2007.07.071_bib33 article-title: Age-related differences in MK-801-and amphetamine-induced locomotor and stereotypic activities of rats publication-title: Neurobiol. Aging doi: 10.1016/S0197-4580(02)00232-4 contributor: fullname: Vasilev – volume: 171 start-page: 391 year: 2001 ident: 10.1016/j.ejphar.2007.07.071_bib34 article-title: Age-related changes in the N-methyl-d-aspartate receptor binding sites within the human basal ganglia publication-title: Exp. Neurol. doi: 10.1006/exnr.2001.7737 contributor: fullname: Villares – volume: 9 start-page: 12 year: 1987 ident: 10.1016/j.ejphar.2007.07.071_bib13 article-title: Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia publication-title: Hillside J. Clin. Psychiatr. contributor: fullname: Javitt – volume: 81 start-page: 173 year: 1990 ident: 10.1016/j.ejphar.2007.07.071_bib31 article-title: MK-801-induced stereotypy and its antagonism by neuroleptic drugs publication-title: J. Neural Transm. Gen. Sect. doi: 10.1007/BF01245040 contributor: fullname: Tiedtke – volume: 13 start-page: 272 year: 1990 ident: 10.1016/j.ejphar.2007.07.071_bib3 article-title: Interactions between glutamatergic and monoaminergic systems within the basal ganglia—implications for schizophrenia and Parkinson's disease publication-title: Trends NeuroSci. doi: 10.1016/0166-2236(90)90108-M contributor: fullname: Carlsson – volume: 32 start-page: 87 year: 1975 ident: 10.1016/j.ejphar.2007.07.071_bib6 article-title: The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(75)90326-X contributor: fullname: Costall – volume: 288 start-page: 699 year: 1999 ident: 10.1016/j.ejphar.2007.07.071_bib16 article-title: Sensitization of amphetamine-induced stereotyped behaviors during the acute response publication-title: J. Pharmacol. Exp. Ther. contributor: fullname: Kuczenski – volume: 36 start-page: 423 year: 1976 ident: 10.1016/j.ejphar.2007.07.071_bib7 article-title: Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(76)90096-0 contributor: fullname: Costall – volume: 907 start-page: 71 year: 2001 ident: 10.1016/j.ejphar.2007.07.071_bib24 article-title: Decline in motor functions in aging is related to the loss of NMDA receptors publication-title: Brain Res. doi: 10.1016/S0006-8993(01)02601-4 contributor: fullname: Ossowska – volume: 2 start-page: 135 year: 1982 ident: 10.1016/j.ejphar.2007.07.071_bib5 article-title: Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [D]cyclohepten-5, 10-immine(MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties publication-title: Drug Dev. Res. doi: 10.1002/ddr.430020204 contributor: fullname: Clineschmidt – volume: 17 start-page: 913 year: 1996 ident: 10.1016/j.ejphar.2007.07.071_bib11 article-title: Neurobehavioral profile of subcutaneously administered MK-801 in the rat publication-title: Neurotoxicology contributor: fullname: Haggerty – volume: 177 start-page: 256 year: 2005 ident: 10.1016/j.ejphar.2007.07.071_bib35 article-title: Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice publication-title: Psychopharmacol. doi: 10.1007/s00213-004-1944-1 contributor: fullname: Wu |
SSID | ssj0005925 |
Score | 2.02462 |
Snippet | Psychomotor effects elicited by systemic administration of the noncompetitive NMDA (
N-methyl-
d-aspartate) receptor antagonist MK-801 (dizocilpine maleate)... Psychomotor effects elicited by systemic administration of the noncompetitive NMDA (N-methyl-D-aspartate) receptor antagonist MK-801 (dizocilpine maleate)... |
SourceID | pubmedcentral crossref pubmed pascalfrancis elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 161 |
SubjectTerms | Age Factors Aging Aging - physiology Animals Biological and medical sciences Differential drug sensitivity Disease Models, Animal Dizocilpine maleate Dizocilpine Maleate - administration & dosage Dizocilpine Maleate - pharmacology Dose-Response Relationship, Drug Excitatory Amino Acid Antagonists - administration & dosage Excitatory Amino Acid Antagonists - pharmacology Locomotion Locomotion - drug effects Male Medical sciences Mice Mice, Inbred C57BL Noncompetitive NMDA receptor antagonist Pharmacology. Drug treatments Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors Schizophrenia - physiopathology Stereotyped Behavior - drug effects Stereotypy |
Title | Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice |
URI | https://dx.doi.org/10.1016/j.ejphar.2007.07.071 https://www.ncbi.nlm.nih.gov/pubmed/18053981 https://pubmed.ncbi.nlm.nih.gov/PMC2705961 |
Volume | 580 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV09b9swED2kzlKgCPpdp6nBocgU1pZEidToGA3cpgkyJEA2lRTJxkEgC7EzeOlv750oxdFQFCjASSIhgke-d4Tu7gF8NpEzynnJ9USWXCTGcWUyx3NvBQkWKmnpj-7ZeTa_Et-v0-sdmHW5MBRW2WJ_wPQGrdsn43Y1x_ViQTm-EYEp3u7IL6D0612kIyEGsDv9djo_30Z65HErZCA4Degy6JowL3db3-j7tpYhtehvDPWi1itcNx8EL54wVj-a8gk9nbyEvdavZNMw9Vew46rXcHgRClNvjtjlNs9qdcQO2cW2ZPXmDfyc_nK8SWtxlnWaKXj279iKAtyDwgRbL9nZKZENx4s8bgnLkAmXQQeI6coyKrrglutNvWGLis1SefxjnDESvH8LVydfL2dz3mov8FLkESnUJ6lPNK6cQobPvZokRnsfa4MuTWRzEXttfeYTb6RDsJV5FosSESFVMhHWJu9gUC0r9wGYUenEx7lN06QUJZ53h5dIrZWdSE99h8C79S7qUGKj6GLPbotgH1LLlEXToiHIzihFb6sUyAL_GDnq2fDxcwQV6LiqIbwPttxORCFK5Yo-2rPyYwcqz91_Uy1umjLdsSRpo2j_v6f7EZ6H6JQY2wEM1vcP7hO6QGszgmdffkejdqP_ARd7Byo |
link.rule.ids | 230,315,786,790,891,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT-MwELUQHBZphWC_KF_rw4oT3jaJEztHqEDdpUUcisQt2LENRSiNaDn0wm9nJk5oc0ArreRT4siWx34zVt7MI-SXDqyW1gmmeiJnPNKWSZ1YljrDUbBQCoN_dEdXyeCG_72Nb9dIv8mFQVpljf0e0yu0rp9069XslpMJ5vgGCKZwu8O4ANOvNzAaQF7X79cVnkca1jIGnGH3Jn-uInnZx_JBPdeVDLEFH_mnz6Wawao5L3ex4q_aXMoV53SxTbbqqJKe-onvkDVbfCHH174s9eKEjpdZVrMTekyvlwWrF1_J3em9ZVVSizW0UUyBk_9EZ0hv9_oSdD6lo0t0NQyu8bAhDAU_OPUqQFQVhmLJBTudL8oFnRS0H4uzYTehKHf_jdxcnI_7A1YrL7CcpwHq00exixSsnAT_njrZi7RyLlQaAprApDx0yrjERU4LC1Ar0iTkOeBBLEXEjYm-k_ViWthdQrWMey5MTRxHOc_htFu4QiolTU847NshrFnvrPQFNrKGefaYefugVqbIqhZ0iGiMkrU2SgY-4B9fHrVs-D4cAgWErbJDfnhbLiciAaNSiYO2rPzeAYtzt98Uk4eqSHcoUNgo2Pvv6f4knwbj0TAb_rm63CebnqcSQjsg6_PnF3sIwdBcH1Wb_Q1y8gf_ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Age-related+differential+sensitivity+to+MK-801-induced+locomotion+and+stereotypy+in+C57BL%2F6+mice&rft.jtitle=European+journal+of+pharmacology&rft.au=Qi%2C+Chunting&rft.au=Zou%2C+Hong&rft.au=Zhang%2C+Ruizhong&rft.au=Zhao%2C+Guoping&rft.date=2008-02-02&rft.pub=Elsevier+B.V&rft.issn=0014-2999&rft.eissn=1879-0712&rft.volume=580&rft.issue=1&rft.spage=161&rft.epage=168&rft_id=info:doi/10.1016%2Fj.ejphar.2007.07.071&rft.externalDocID=S0014299907012381 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2999&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2999&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2999&client=summon |